Tri-Legest Fe

Endometriosis, Low Testosterone, Osteoporosis + 16 more

Treatment

20 Active Studies for Tri-Legest Fe

Treatment for

Endometriosis

What is Tri-Legest Fe

NorethisteroneThe Generic name of this drug

Treatment SummaryEthinylestradiol was developed in 1938 and is used as a form of estrogen with improved absorption when taken orally. It is most commonly used in contraceptive pills and was approved by the FDA in 1943.

Neconis the brand name

image of different drug pills on a surface

Tri-Legest Fe Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Necon

Norethisterone

1967

347

Effectiveness

How Tri-Legest Fe Affects PatientsEthinylestradiol is a type of synthetic hormone (estrogen) that prevents ovulation by decreasing hormones in the body responsible for ovulation. It can be taken once a day and is considered safe, although patients should be aware of the risks of clots.

How Tri-Legest Fe works in the bodyEthinylestradiol is a synthetic estrogen that is used in birth control pills. It works by reducing the hormones needed to ovulate, making the cervical mucus thicker so sperm cannot pass through, and preventing changes in the uterus that would allow a fertilized egg to implant. It also lowers luteinizing hormone levels and increases sex hormone binding globulin.

When to interrupt dosage

The prescribed amount of Tri-Legest Fe is contingent upon the diagnosed condition, such as Acne Vulgaris, Hormonal Contraception and Folate supplementation therapy. The dosage likewise changes depending on the administration approach detailed in the table beneath.

Condition

Dosage

Administration

Hot flashes

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormone Replacement Therapy

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Atrophic

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

female castration

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Low Testosterone

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

hypoestrogenism

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Therapeutic procedure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Fracture

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Ovarian Failure

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Postmenopausal Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Vasomotor System

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Oral Contraceptives

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Hormonal Contraception

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Estrogen Deprivation Symptoms

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Menopause

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Birth Control

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Osteoporosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Endometriosis

0.014 mg/hour, , 0.025 mg/hour, 0.5 mg, 0.1 mg, 5.0 mg, 1.0 mg, 0.35 mg, 1.5 mg, 0.8 mg, 2.7 mg, 4.8 mg, 0.75 mg, 0.4 mg, 2.25 mg, 30.0 mg, 3.0 mg

Transdermal, Patch, extended release, , Patch, extended release - Transdermal, Kit, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Kit - Oral, Patch, Patch - Transdermal, Tablet, chewable, Tablet, chewable - Oral, Capsule - Oral, Capsule, Intramuscular; Oral; Topical

Warnings

Tri-Legest Fe has twenty-six contraindications, hence it should not be compounded with any of the conditions enumerated in the following table.Tri-Legest Fe Contraindications

Condition

Risk Level

Notes

active liver disease

Do Not Combine

Thrombophilia

Do Not Combine

Vaginal Hemorrhage

Do Not Combine

Malignant Neoplasms

Do Not Combine

Benign hepatic neoplasm

Do Not Combine

Breast Cancer

Do Not Combine

Thromboembolism

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Norethisterone may interact with Pulse Frequency

There are 20 known major drug interactions with Tri-Legest Fe.

Common Tri-Legest Fe Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Norethisterone.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Norethisterone.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Norethisterone.

Clomipramine

Major

The metabolism of Clomipramine can be increased when combined with Norethisterone.

Copanlisib

Major

The metabolism of Copanlisib can be decreased when combined with Norethisterone.

Tri-Legest Fe Toxicity & Overdose RiskWomen who overdose on contraceptives may experience a lack of normal menstrual bleeding, nausea, vomiting, breast tenderness, abdominal pain, drowsiness, and fatigue. Treatment of the overdose should include monitoring of potassium and sodium levels in the blood as well as signs of metabolic acidosis.

Tri-Legest Fe Novel Uses: Which Conditions Have a Clinical Trial Featuring Tri-Legest Fe?

38 active clinical trials are examining the potential of Tri-Legest Fe for Folate supplementation, Premenstrual Dysphoric Disorder and Menopausal symptom management.

Condition

Clinical Trials

Trial Phases

Birth Control

31 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Early Phase 1

Estrogen Deprivation Symptoms

0 Actively Recruiting

Hot flashes

22 Actively Recruiting

Phase 2, Not Applicable, Phase 1, Phase 4, Early Phase 1

Endometriosis

32 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 2, Phase 4, Phase 1

Oral Contraceptives

2 Actively Recruiting

Not Applicable

Osteoporosis

40 Actively Recruiting

Phase 1, Phase 2, Not Applicable, Early Phase 1, Phase 4, Phase 3

Therapeutic procedure

0 Actively Recruiting

Low Testosterone

15 Actively Recruiting

Phase 1, Phase 4, Phase 2, Not Applicable

Menopause

0 Actively Recruiting

Hormone Replacement Therapy

0 Actively Recruiting

Atrophic

5 Actively Recruiting

Phase 2, Phase 4, Not Applicable

Postmenopausal Osteoporosis

3 Actively Recruiting

Not Applicable, Phase 4

Fracture

0 Actively Recruiting

female castration

0 Actively Recruiting

hypoestrogenism

2 Actively Recruiting

Phase 4

Vasomotor System

0 Actively Recruiting

Endometriosis

1 Actively Recruiting

Phase 4

Ovarian Failure

2 Actively Recruiting

Not Applicable, Phase 1

Hormonal Contraception

0 Actively Recruiting

Tri-Legest Fe Reviews: What are patients saying about Tri-Legest Fe?

5Patient Review

6/3/2014

Tri-Legest Fe for Acne

I experienced no bloating, breast growth, weight gain, or mood swings. My period was also lighter (2-3 days). However, my skin got worse after starting to use it.

5Patient Review

4/13/2016

Tri-Legest Fe for Birth Control

I was really pleased with this treatment--I didn't experience any weight gain, my acne decreased, and my moods were more stable. My period was also lighter than usual, which was an added bonus.

5Patient Review

11/27/2019

Tri-Legest Fe for Birth Control

Though this medication alleviated my period pain and made my periods lighter, after seven months of taking it I experienced increased depression and suicidality. Additionally, it did nothing for my acne.

4.7Patient Review

9/11/2015

Tri-Legest Fe for Birth Control

I took this for acne as well as birth control. The first month I had a lot of side effects such as mood swings, headaches, and the acne got worse. However, after using it for a couple of months all the side effects went away. My breasts grew a little and I didn't gain any weight. My acne persisted for about 6-8 months but then it began to clear up dramatically! Now my skin is better than it has ever been before. Once my body adjusted it worked wonderfully.

4.7Patient Review

11/10/2015

Tri-Legest Fe for Acne

I've only been taking this medication for three weeks, but I'm already seeing results that I like. At first, I felt a little nauseous after taking the pink pills, but now I'm feeling fine. I have more energy and don't feel depressed. This is by far the best birth control option I've tried (IUDs included).

4.7Patient Review

6/23/2016

Tri-Legest Fe for Birth Control

Unfortunately, this pill caused me to break out all over my chin and cheeks. I never had that problem before. Additionally, it made my periods more painful with cramps and bloating.

4.3Patient Review

4/26/2014

Tri-Legest Fe for Birth Control

I tried this generic version of estrostep, and while it was cheaper, I didn't like it as much. I felt bloated and gassy all the time, and my periods were lighter and less regular. I'll be switching back next month.

4.3Patient Review

7/17/2015

Tri-Legest Fe for Acne

I was given the generic form of this drug when my pharmacy was out of estrostep fe, and I have not had a good experience with it. In the two months that I've been taking it, I've gained weight, felt more PMS symptoms, and gotten dizzy spells more frequently. I'm glad to be done with it and going back to the original formulation that I know works well for me.

3.7Patient Review

4/19/2019

Tri-Legest Fe for Painful Periods

This pill did stop my irregular period, however, the side effects were not worth it. I felt dizzy and lightheaded constantly, and the cramps I experienced during my first period on the pill were unbearable.

3.7Patient Review

6/29/2014

Tri-Legest Fe for Birth Control

I'm currently on my third week of pills and have noticed extreme emotional changes. The second week was especially hard in terms of ravenous cravings, but that has since subsided. However, I am now dealing with water retention and painfully swollen breasts.

3.7Patient Review

2/16/2014

Tri-Legest Fe for Birth Control

I've been on this medication for my acne for a while now, and it does a decent job of keeping things under control--though not perfectly. One downside is that I occasionally get breakthrough bleeding a few weeks into each new pack.

3.7Patient Review

5/8/2022

Tri-Legest Fe for Premenstrual Disorder with a State of Unhappiness

I started taking tri legest fe to help with my acne, but it actually made it worse. In addition, I experienced bloating, cramps, fatigue, and increased mood swings and anxiety. The only positive aspect of this medication was that my periods became lighter and shorter. Overall, I would not recommend this birth control to anyone.

3.3Patient Review

9/24/2014

Tri-Legest Fe for Birth Control

While this birth control has been effective in preventing pregnancy, the side effects have been really tough to deal with. Bloating, stomach pain, constipation, and tender breasts are all constant issues I've experienced. Additionally, it made my acne much worse than it was before.

3.3Patient Review

11/11/2013

Tri-Legest Fe for Acne

3.3Patient Review

6/22/2014

Tri-Legest Fe for Birth Control

I really liked Tri Legest Fe. I only stopped taking it because it got too expensive and my new insurance wouldn't cover it. It did a great job reducing my acne, and I didn't have any mood swings while on it. I also didn't gain any weight, which is something that happened when I first started taking birth control (Yaz).

2.7Patient Review

5/21/2015

Tri-Legest Fe for Premenstrual Disorder with a State of Unhappiness

I've been taking this treatment for three months now, and I can say with certainty that it has changed me for the worse. I'm more irritable and quick to anger than ever before, and my anxiety issues have come back with a vengeance. Plus, I haven't wanted to have sex since starting this medication--which was the whole reason I started taking birth control in the first place. Needless to say, I'll be exploring other options from here on out.

2Patient Review

5/10/2016

Tri-Legest Fe for Birth Control

I got pregnant the first month I stopped taking birth control pills, which was great. Not having to worry about messing up my pill schedule or whether or not my body's hormones were aligning properly made things much easier.

Patient Q&A Section about tri-legest fe

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Tri Legest Fe generic for?

"Tri-Legest is a combined oral contraceptive indicated for the prevention of pregnancy. It is a progestin and estrogen combination pill that is taken once daily."

Answered by AI

Is Tilia Fe the same as Tri Legest?

"This text is discussing a generic equivalent to the drug ESTROSTEP Fe. The generic equivalent is called Tri-Legest Fe."

Answered by AI

Is Tri Legest Fe good for acne?

"The medication NORETHINDRONE ACETATE; ETHINYL ESTRADIOL; FERROUS FUMARATE is used to prevent ovulation and pregnancy. It may also be used to treat acne."

Answered by AI

What hormones are in Tri Legest Fe?

"The pill consists of two hormones, norethindrone (a progestin) and ethinyl estradiol (an estrogen), as well as a small amount of iron (ferrous fumarate) in the seven inactive pills taken during the fourth week. The inactive pills don't contain any hormones."

Answered by AI

Clinical Trials for Tri-Legest Fe

Image of University of Colorado Department of Obstetrics & Gynecology in Aurora, United States.

Elagolix for Infertility

This trial is testing a new medication given by mouth to women with endometriosis who are trying to get pregnant through IVF. The main goal is to see if the medication can increase the chances

University of Colorado Department of Obstetrics & Gynecology (+4 Sites)Hugh Taylor, MD

Image of University of Michigan in Ann Arbor, United States.

My Pelvic Plan Website for Endometriosis

This trial aims to see if an online self-management program can help patients with Chronic Pelvic Pain feel better. The researchers believe that patients using the program will have less pain, better physical function, and

Waitlist Available

University of MichiganSara Till, MD

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Desogestrel / Ethinyl Estradiol Pill for Birth Control

This trial aims to understand how differences in our DNA can affect how our bodies process hormones in birth control pills, potentially influencing their effectiveness in preventing pregnancy and causing different side effects in individuals. Participants will take

Waitlist Available

University of Colorado Anschutz Medical Campus (+1 Sites)Aaron M Lazorwitz, MD, PhD

Image of McLean Function Measurement Lab in Ottawa, Canada.

Repetitive Transcranial Magnetic Stimulation for Endometriosis

This trial aims to improve pain outcomes for Canadian women with endometriosis. It will test the effectiveness of a repetitive transcranial magnetic stimulation (rTMS) intervention for reducing pain in individuals

No Prior Treatment

McLean Function Measurement LabLinda McLean, PhD

Have you considered Tri-Legest Fe clinical trials? We made a collection of clinical trials featuring Tri-Legest Fe, we think they might fit your search criteria.

Explore trials for Tri-Legest Fe

Image of University of Central Florida in Orlando, United States.

Wrist/hand immobilization for Menstruation

"This trial aims to understand why females tend to get more hand and wrist injuries compared to males in sports. The study will look at the impact of hormones, such as those from birth control, on muscle

University of Central Florida

Image of University of Colorado Anschutz Medical Campus in Aurora, United States.

Transdermal Estradiol Patch +2 More for Menopause

"This trial aims to study how the decrease in estrogen during menopause affects artery health and body fat distribution in women. The researchers will investigate whether low estrogen levels lead to decreased artery function and increased fat in

Waitlist Available

University of Colorado Anschutz Medical CampusKerrie Moreau, PhD

Image of University of Kentucky in Lexington, United States.

Alendronate for Osteoporosis

This trial aims to address the issue of age-related bone loss, which is often overlooked in current osteoporosis treatments. The study compares the effectiveness of two drugs, Alendronate and Terip

Waitlist Available

University of KentuckyHartmut H Malluche, MD

Image of Hybl Sports Medicine and Performance Center in Colorado Springs, United States.

Hot Water Therapy for Menopause

Colorado Springs, CO

This trial is studying the effects of hot water therapy on menopausal women. The researchers want to see if taking hot baths for multiple days in a row can reduce hot flash symptoms and improve mood.

Hybl Sports Medicine and Performance CenterNathan Morris, PhD

Have you considered Tri-Legest Fe clinical trials? We made a collection of clinical trials featuring Tri-Legest Fe, we think they might fit your search criteria.

Explore trials for Tri-Legest Fe

Image of University of Arizona in Tucson, United States.

PhytoSERM for Hot Flashes

This trial is testing the effects of a supplement called PhytoSERM on menopausal symptoms in women. Participants will either take PhytoSERM pills or a placebo for 12 weeks. After

University of ArizonaFei Yin, PhDNeuTherapeutics

Image of Citruslabs in Santa Monica, United States.

Probiotic Supplement for Menopause Symptoms

Santa Monica, CA

This trial tests if a probiotic supplement can reduce menopause symptoms like hot flashes, night sweats, mood swings, etc. Participants take a test product or placebo daily and provide data on weight, waist, sleep, and symptoms.

Waitlist Available

Dietary Supplement

CitruslabsManeuver Marketing

Image of Planned Parenthood of Northern California in Berkeley, United States.

Ovaprene for Birth Control

This trial will study a new, non-hormonal contraceptive ring for safety, effectiveness, and acceptability.

Planned Parenthood of Northern California (+20 Sites)Christine Mauck, MDDaré Bioscience, Inc.

Image of St. Barnabas Woodlands in Pittsburgh, United States.

Denosumab +1 More for Osteoporosis

This trial aims to show that a new medication called Denosumab can help older adults who are weak and frail by improving their muscle health, strength, mobility, and overall function.

St. Barnabas Woodlands

Have you considered Tri-Legest Fe clinical trials? We made a collection of clinical trials featuring Tri-Legest Fe, we think they might fit your search criteria.

Explore trials for Tri-Legest Fe

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security